147 related articles for article (PubMed ID: 36257179)
21. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
[TBL] [Abstract][Full Text] [Related]
22. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
[TBL] [Abstract][Full Text] [Related]
23. Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.
Kamran SC; Clark JW; Zheng H; Borger DR; Blaszkowsky LS; Allen JN; Kwak EL; Wo JY; Parikh AR; Nipp RD; Murphy JE; Goyal L; Zhu AX; Iafrate AJ; Corcoran RB; Ryan DP; Hong TS
Cancer Med; 2018 Jul; 7(7):2934-2942. PubMed ID: 29771009
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
[TBL] [Abstract][Full Text] [Related]
26. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
[TBL] [Abstract][Full Text] [Related]
27. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
Wang K; Xu D; Yan XL; Poston G; Xing BC
Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
[TBL] [Abstract][Full Text] [Related]
28. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
[TBL] [Abstract][Full Text] [Related]
29. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of colorectal cancer patients with bone metastases: a single-center experience.
Li T; Jing H; Zhang Y; Cao Z; Zhao L; Zhang X; Sun T; Zhang M
Updates Surg; 2023 Dec; 75(8):2245-2256. PubMed ID: 37976001
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer.
Kubeček O; Laco J; Špaček J; Kubečková A; Petera J; Krulichová IS; Bezrouk A; Filip S; Kopecký J
Curr Oncol; 2021 Aug; 28(4):2914-2927. PubMed ID: 34436021
[TBL] [Abstract][Full Text] [Related]
33. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
[TBL] [Abstract][Full Text] [Related]
34. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A).
Ouchi A; Sadachi R; Hamaguchi T; Tsukamoto S; Shimada Y; Inomata M; Takii Y; Komori K; Shiomi A; Shiozawa M; Ohue M; Watanabe J; Ito M; Kawashima Y; Kobatake T; Souda H; Saida Y; Hashimoto T; Sano Y; Kanemitsu Y;
Ann Surg; 2024 Feb; 279(2):283-289. PubMed ID: 37551612
[TBL] [Abstract][Full Text] [Related]
36. Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population-based study and meta-analysis.
van der Kruijssen DEW; van der Kuil AJS; Vink GR; Punt CJA; de Wilt JHW; Elias SG; Koopman M
Int J Cancer; 2023 Apr; 152(7):1360-1369. PubMed ID: 36346099
[TBL] [Abstract][Full Text] [Related]
37. The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
Demurtas L; Puzzoni M; Giampieri R; Ziranu P; Pusceddu V; Mandolesi A; Cremolini C; Masi G; Gelsomino F; Antoniotti C; Loretelli C; Meriggi F; Zaniboni A; Falcone A; Cascinu S; Scartozzi M
Br J Cancer; 2017 Jul; 117(3):315-321. PubMed ID: 28632725
[TBL] [Abstract][Full Text] [Related]
38. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
[TBL] [Abstract][Full Text] [Related]
39. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
40. Brain metastases in colorectal cancer: prognostic factors and survival analysis.
Del Carpio Huerta L; Virgili Manrique AC; Szafranska J; Martin-Richard M; Paez Lopez-Bravo D; Sebio Garcia A; Espinosa Mariscal I; Gomila Pons P; Andres Granyo M; Barba Joaquin A; Barnadas Molins A; Tobeña Puyal M
Int J Colorectal Dis; 2018 Nov; 33(11):1517-1523. PubMed ID: 29943356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
